About 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid
4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid (PubChem CID 175693189) has the molecular formula C31H38F3N5O4
and a molecular weight of 601.67 g/mol. Its IUPAC name is 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid.
Molecular Properties
| Compound Name | 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid |
| PubChem CID | 175693189 |
| Molecular Formula | C31H38F3N5O4 |
| Molecular Weight | 601.67 g/mol |
| Exact Mass | 601.29 |
| IUPAC Name | 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid |
| SMILES | COc1cc2nn(C3CCC(CN(C)CCC4CCN(C(=O)O)CC4)CC3)cc2cc1C(=O)c1cccc(C(F)(F)F)n1 |
| InChI | InChI=1S/C31H38F3N5O4/c1-37(13-10-20-11-14-38(15-12-20)30(41)42)18-21-6-8-23(9-7-21)39-19-22-16-24(27(43-2)17-26(22)36-39)29(40)25-4-3-5-28(35-25)31(32,33)34/h3-5,16-17,19-21,23H,6-15,18H2,1-2H3,(H,41,42) |
| InChIKey | DQKJTWZKXNSMHE-UHFFFAOYSA-N |
| XLogP | 6.13 |
| TPSA | 100.79 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 601.67 |
| LogP ≤ 5 | 6.13 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid?
The IUPAC name of 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid (CID 175693189) is 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid.
What is the SMILES notation for 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid?
The canonical SMILES for 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid is COc1cc2nn(C3CCC(CN(C)CCC4CCN(C(=O)O)CC4)CC3)cc2cc1C(=O)c1cccc(C(F)(F)F)n1.
What is the InChIKey of 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid?
The InChIKey is DQKJTWZKXNSMHE-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H38F3N5O4/c1-37(13-10-20-11-14-38(15-12-20)30(41)42)18-21-6-8-23(9-7-21)39-19-22-16-24(27(43-2)17-26(22)36-39)29(40)25-4-3-5-28(35-25)31(32,33)34/h3-5,16-17,19-21,23H,6-15,18H2,1-2H3,(H,41,42).
What are the key properties of 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid?
4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid has a molecular weight of 601.67 g/mol, XLogP of 6.13, 9 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-[[4-[6-methoxy-5-[6-(trifluoromethyl)pyridine-2-carbonyl]indazol-2-yl]cyclohexyl]methyl-methylamino]ethyl]piperidine-1-carboxylic acid is sourced from PubChem (CID 175693189), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).